Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SP-2-225 |
Synonyms | |
Therapy Description |
SP-2-225 selectively inhibits HDAC6, which potentially results in increased anti-tumor immune response and decreased tumor growth (PMID: 37586844) |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SP-2-225 | HDAC Inhibitor 45 | SP-2-225 selectively inhibits HDAC6, which potentially results in increased anti-tumor immune response and decreased tumor growth (PMID: 37586844) |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|